- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04481074
Inspiratory Muscle Training in Patients With Interstitial Lung Disease (IMT-ILD)
February 2, 2022 updated by: Veronica Franco Parreira, Federal University of Minas Gerais
Effects of Inspiratory Muscle Training in Inspiratory Muscle Endurance, Breathlessness, Inspiratory Muscle Strength, Functional Capacity and Quality of Life in Patients With Interstitial Lung Disease
The aim of this study is to evaluate the effects of inspiratory muscle training program in inspiratory muscle endurance, breathlessness, inspiratory muscle strength, functional capacity and quality of life in patients with interstitial lung disease.
Patients are evaluated before the inspiratory muscle training and after 8 weeks of training.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Inspiratory Muscle Training has been described as an effective intervention and contribute to the improvement of inspiratory muscle function and breathlessness in patients with chronic lung disease.
The aim of this study is to evaluate, the effects of inspiratory muscle endurance, breathlessness, inspiratory muscle strength, functional capacity and quality of life in patients with interstitial lung disease.
It is a quasi-experimental study.
Patients with interstitial lung disease are recruited from interstitial disease ambulatory.
In each session patients performs two times 30 breaths with a minute rest between them.
The load is set according with 50% of actual PImax, the Borg score should be between 4 and 6, otherwise the load will decrease (if Borg more than 6) or increase (if Borg less than 4).
New PImax is measured weekly and the new load is defined following the same protocol for 8 weeks.
Patients are evaluated before the inspiratory muscle training and after 8 weeks of training.
Study Type
Interventional
Enrollment (Actual)
14
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Minas Gerais
-
Belo Horizonte, Minas Gerais, Brazil, 30150-260
- Ambulatório Bias Fortes - Ambulatório de Doenças Intersticiais do Hospital das Clínicas da Universidade Federal de Minas Gerais.
-
Belo Horizonte, Minas Gerais, Brazil, 31270-901
- Laboratório de Avaliação e Pesquisa em Desempenho Cardiorrespiratório da UFMG
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years to 80 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Clinical and radiological diagnosis of interstitial lung disease established by a pulmonologist;
- Absence of clinical exacerbations of the disease in the four weeks prior to the initial data collection;
- Present medical research council scale more than 2;
- Absence of a associated or self reported cardiac, orthopedic and psychiatric diseases,
- Not participating in pulmonary rehabilitation programs;
- Do not use supplemental oxygen therapy while resting.
Exclusion Criteria:
- Inability of the participant to understand or perform the procedures proposed during the evaluations and training program.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: OTHER
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Inspiratory muscle training group
Group intervention: home-based interval inspiratory muscle training during 8 weeks, two sessions with two sets of 30 breaths with one minute rest between them.
Load set is determinated weekly, aiming 50% of actual PImax and according to Borg Score.
|
Inspiratory muscle training will be performed using the tapered flow-resistive loading trainer (POWERbreathe®).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Inspiratory muscle endurance
Time Frame: At baseline and after 8 weeks of training
|
Endurance time in seconds
|
At baseline and after 8 weeks of training
|
Change in Breathlessness
Time Frame: At baseline and after 8 weeks of training
|
Medical Research Council (1-5)
|
At baseline and after 8 weeks of training
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Inspiratory muscle strength
Time Frame: At baseline and after 8 weeks of training
|
Maximal inspiratory pressure in cmH20
|
At baseline and after 8 weeks of training
|
Change in Functional capacity
Time Frame: At baseline and after 8 weeks of training
|
Maximal distance in 6 minute walk test
|
At baseline and after 8 weeks of training
|
Change in Quality of life
Time Frame: At baseline and after 8 weeks of training
|
King's Brief Interstitial Lung Disease Questionnaire.
It is a 15 questions questionnaire.
Total score can go from 0 - 100, 100 is the better quality of life.
|
At baseline and after 8 weeks of training
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
July 30, 2020
Primary Completion (ACTUAL)
April 30, 2021
Study Completion (ACTUAL)
April 30, 2021
Study Registration Dates
First Submitted
July 17, 2020
First Submitted That Met QC Criteria
July 17, 2020
First Posted (ACTUAL)
July 22, 2020
Study Record Updates
Last Update Posted (ACTUAL)
February 3, 2022
Last Update Submitted That Met QC Criteria
February 2, 2022
Last Verified
February 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- UFMG_IMT-ILD
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Idiopathic Pulmonary Fibrosis
-
St. Antonius HospitalZonMw: The Netherlands Organisation for Health Research and Development; Boeringer...RecruitingPulmonary Fibrosis Idiopathic FamilialNetherlands
-
Sheba Medical CenterUnknownIDIOPATHIC PULMONARY FIBROSISIsrael
-
Wake Forest University Health SciencesMayo Clinic; The University of Texas Health Science Center at San AntonioCompletedIdiopathic Pulmonary Fibrosis (IPF)United States
-
Theravance BiopharmaTerminatedIdiopathic Pulmonary Fibrosis (IPF)United Kingdom
-
University of California, San FranciscoCompletedIdiopathic Pulmonary Fibrosis (IPF)United States
-
BiogenCompletedIdiopathic Pulmonary Fibrosis (IPF)United States
-
Liminal BioSciences Ltd.CompletedIdiopathic Pulmonary Fibrosis (IPF)Canada
-
Bristol-Myers SquibbCompletedIdiopathic Pulmonary Fibrosis (IPF)United States
-
Angion Biomedica CorpNot yet recruitingIdiopathic Pulmonary Fibrosis (IPF)
-
Xfibra, Inc.Not yet recruitingIdiopathic Pulmonary Fibrosis (IPF)
Clinical Trials on Inspiratory muscle training
-
Elisabethinen HospitalUnknownStem Cell Transplantation | Inspiratory Muscle Training | Respiratory Muscle TrainingAustria
-
Dokuz Eylul UniversityDokuz Eylül University, Scientific Research Projects Coordination UnitCompleted
-
University of British ColumbiaNatural Sciences and Engineering Research Council, CanadaCompletedRespiratory Muscles | Breathing ExercisesCanada
-
King Saud UniversityCompleted
-
Universidad Complutense de MadridColegio Profesional de Fisioterapeutas de la Comunidad de Madrid, Madrid,...CompletedQuality of Life | Covid19 | Respiratory Muscle Training | Respiratory Function Test | Psychosocial FactorSpain
-
Universidade do PortoUnknownMuscle Weakness | Dyspnea | Reactive Airways Dysfunction Syndrome (Disorder)Portugal
-
Gazi UniversityCompletedAllogeneic Hematopoietic Stem Cell Transplantation
-
Gazi UniversityCompleted
-
Federal University of Health Science of Porto AlegreIrmandade Santa Casa de Misericórdia de Porto AlegreUnknownChronic Kidney Disease